EngagedToMS wrote:I met a guy that was working at a funky little used record/CD store whose sister has MS. He said that ONE hit from a joint, it was as if she didn't even have MS. I understand MS is different in every patient and that drugs effect people differently. But for those that could benefit, it is more criminal to deny an MS sufferer something that bring relief.
It's a bigger question than the original post, but how do trials cater for treatments that work for some patients and not for others? It is reasonable to think that a specific treatment may only benefit a specifc group of patients. In trials, these people would lower the statistical scores as to the effectiveness of the treatment. Until the people running the trials can understand how to differentiate these people, I do not see how they will differentiate the responders from the general placebo crowd in a population.ElliotB wrote:I have successfully been using CBD oil for the past few months and continue to use it and it seems to help with my pain (less episodes and less intensity). I have not tried any form of cannabis.
ElliotB wrote: I have often wondered about the overall validity of trials, as it is my understanding that participants are hand selected and only those that it is felt will positively affect the desired results are selected.
Users browsing this forum: No registered users